LGND ligand.com Operating Profitability

Public company logo of Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals (LGND) generates revenue through the licensing of its Captisol platform and royalties, maintaining environmental compliance by keeping its own production volumes low. The operating margin breakdown demonstrates the resilience of the business model, with the value holding at 14.40. Profitability is based on partnerships with biopharmaceutical giants that make milestone payments for the use of the company's scientific developments.

LGND: Ligand Pharmaceuticals Incorporated Return on Sales by Operating Profit 07/04/2022 - 11/20/2026

Ligand Pharmaceuticals (LGND) - metric breakdowns and financial figures

- market capitalization data:
Fundamental company valuation:Ligand Pharmaceuticals Incorporated, LGND
Core merchandise of Ligand Corp

Ligand Pharmaceuticals (LGND) operates in a high-risk sector where financial stability depends directly on the commercial success of partner drugs and patent protection. By analyzing the operating margin distribution, an investor assesses the share of profit from core operations relative to total revenue, which helps identify cost management efficiency and the risks of declining royalties before taxes and interest obligations.

Main competitors

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Profitability Amneal AMRX|Operating Profitability Margin Perrigo Company PLC|Alvotech Biopharmaceuticals - Operating Margin|Profitability of Operations Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Operating Profitability|anipharmaceuticals.com - Operating Profit Rate|Operating Sales Margin MNKD|AMPH: Operating Profit Rate|Operating Profitability pacira.com (PCRX)|Operating Margin ARS Pharma (SPRY)|Theravance Biopharma - Operating Sales Margin|Operating Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Operating Sales Margin|Operating Return on Sales Tectonic Therapeutic|TNXP: Operating Margin|SXT China (SXTC) - Operating Margin|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.